[
    [
        {
            "time": "2023-07-15",
            "original_text": "暴走A股：明天！见证A股历史",
            "features": {
                "keywords": [
                    "A股",
                    "历史",
                    "暴走"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "全市场"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "暴走A股：明天！见证A股历史",
                "Correlation": 6,
                "Sentiment": 5,
                "Importance": 7,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 3,
                "Market_Scope": 8,
                "Time_Proximity": 9,
                "Headline_Structure": 10,
                "Source_Recency": 9
            }
        },
        {
            "time": "2023-07-15",
            "original_text": "北向资金再卖27亿：科技股领跌两大“酒王”被抛售逾16亿",
            "features": {
                "keywords": [
                    "北向资金",
                    "科技股",
                    "酒王",
                    "抛售"
                ],
                "sentiment_score": -0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "白酒",
                    "科技"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "北向资金再卖27亿：科技股领跌两大“酒王”被抛售逾16亿",
                "Correlation": 9,
                "Sentiment": 4,
                "Importance": 8,
                "Impact": 8,
                "Duration": 6,
                "Entity_Density": 7,
                "Market_Scope": 7,
                "Time_Proximity": 8,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        },
        {
            "time": "2023-07-15",
            "original_text": "恒瑞医药：药监局同意SHR-1703注射液开展临床试验",
            "features": {
                "keywords": [
                    "恒瑞医药",
                    "临床试验",
                    "SHR-1703"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "恒瑞医药：药监局同意SHR-1703注射液开展临床试验",
                "Correlation": 10,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 7,
                "Duration": 8,
                "Entity_Density": 9,
                "Market_Scope": 5,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "2023-07-15",
            "original_text": "君实生物科创板IPO：市值超千亿！高瓴最早投资，收益超10倍",
            "features": {
                "keywords": [
                    "君实生物",
                    "科创板",
                    "IPO",
                    "高瓴资本"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药",
                    "生物科技"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "君实生物科创板IPO：市值超千亿！高瓴最早投资，收益超10倍",
                "Correlation": 9,
                "Sentiment": 9,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 8,
                "Market_Scope": 6,
                "Time_Proximity": 7,
                "Headline_Structure": 9,
                "Source_Recency": 8
            }
        },
        {
            "time": "2023-07-15",
            "original_text": "北水连续六日加仓腾讯、疯狂抛售中芯国际；南水逆势买入恒瑞医药",
            "features": {
                "keywords": [
                    "北水",
                    "腾讯",
                    "中芯国际",
                    "恒瑞医药",
                    "加仓",
                    "抛售"
                ],
                "sentiment_score": -0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "科技",
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "mixed",
                "affected_by_time_series": "true",
                "ts_effect_direction": "mixed"
            },
            "scores": {
                "News_content": "北水连续六日加仓腾讯、疯狂抛售中芯国际；南水逆势买入恒瑞医药",
                "Correlation": 9,
                "Sentiment": 6,
                "Importance": 8,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 8,
                "Market_Scope": 7,
                "Time_Proximity": 8,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        },
        {
            "time": "2023-07-15",
            "original_text": "复星医药强势涨停、恒瑞医药再创新高，提振创新药板块",
            "features": {
                "keywords": [
                    "复星医药",
                    "恒瑞医药",
                    "涨停",
                    "创新药"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "复星医药强势涨停、恒瑞医药再创新高，提振创新药板块",
                "Correlation": 9,
                "Sentiment": 9,
                "Importance": 8,
                "Impact": 8,
                "Duration": 6,
                "Entity_Density": 8,
                "Market_Scope": 7,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        },
        {
            "time": "2023-07-15",
            "original_text": "智飞生物新冠疫苗启动Ⅱ期临床，疫苗板块持续走强——医药行业周报",
            "features": {
                "keywords": [
                    "智飞生物",
                    "新冠疫苗",
                    "临床试验",
                    "疫苗板块"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药",
                    "疫苗"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "智飞生物新冠疫苗启动Ⅱ期临床，疫苗板块持续走强——医药行业周报",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 7,
                "Duration": 8,
                "Entity_Density": 7,
                "Market_Scope": 8,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        }
    ]
]